Flerie publishes merger document with Biosergen
Flerie AB and Biosergen have adopted a merger plan where Biosergen will be absorbed by Flerie. Biosergen's operations will be transferred to a new Flerie subsidiary.
Flerie AB (publ) and Biosergen have jointly adopted a merger plan, as announced on June 26, 2026. The plan details the absorption of Biosergen by Flerie.
Following the completion of the merger, Biosergen's operations will be contributed to a new subsidiary of Flerie's wholly owned subsidiary, Flerie Invest AB.
The merger document provides further details on the transaction. This consolidation is expected to strengthen Flerie's position within its sector. The announcement explicitly states this communication is not intended for distribution in certain territories, including the United States.